If the company replied to emails and calls the price would be $1.
I had similar experiences.
Company is totally focused on its tasks and assumes market will take care of itself.
Big pharma candidate would not have requested second lot of tests if it were not interested.
Great to see CEO decided to produce test internally. Apparantly not very costly to do and its right up their alley.
I run a model on some of these small cap tech/bio stocks. This tops my list.
Ann: Proteomics gaining strong traction in Analytical Services-PIQ.AX, page-9
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
84.5¢ |
Change
-0.015(1.74%) |
Mkt cap ! $110.6M | |||
| Open | High | Low | Value | Volume |
| 86.0¢ | 86.5¢ | 84.0¢ | $48.13K | 56.58K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 53678 | 84.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.5¢ | 13825 | 2 |
View Market Depth
| Last trade - 14.58pm 07/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |